Organization · Corporate Venture Capital
ONCE Ventures
ONCE Ventures is the corporate venture capital arm of Otsuka Nutraceuticals, focusing on consumer health investments in North America. They partner with early-stage companies in sectors like longevity, microbiome, and personalized nutrition.
Overview
What ONCE Ventures does
What ONCE Ventures is
ONCE Ventures is the corporate venture capital arm of Otsuka Nutraceuticals, focusing on consumer health investments in North America. They partner with early-stage companies in sectors like longevity, microbiome, and personalized nutrition.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Corporate Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- May 3, 2026
Official channels
Find ONCE Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
ONCE Ventures as a funder
Investment thesis
ONCE Ventures invests where consumer-health products or technologies can benefit from Otsuka nutraceutical, regulatory, brand, retail, and manufacturing capabilities. They focus on companies that align with Otsuka's mission to create and maintain better health worldwide.
Focus narrative
ONCE Ventures invests in advancements across various health-related sectors, including longevity, microbiome, personalized nutrition, mental wellness, and women's health. They are particularly interested in companies that demonstrate revenue of over $1 million or possess strong clinical evidence available to consumers without a prescription.
Value beyond capital
ONCE Ventures provides strategic support tied to Otsuka's capabilities, including go-to-market strategies, R&D, manufacturing, regulatory guidance, and brand-building assistance, helping portfolio companies scale effectively.
Terms and economics
- Typical check
- $1,000,000–$5,000,000
- Sweet spot
- $3,000,000
Focus and fit
- Stages
- Series A · Series B · Friends and Family · Angel · Accelerator · Pre-seed · Seed · Seed+ · Growth Equity
- Sectors
- Longevity · Microbiome · Mental Health · Healthcare · Biotech · Consumer · Digital Health
- Regions
- North America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 5
- Recorded notable exits
- Prenexus Health and Your Super
Portfolio context
Notable portfolio companies include Kanza AI, Solaria Bio, Curio Digital Therapeutics, New Culture, and Vivoo. These companies represent ONCE Ventures' commitment to investing in innovative solutions that enhance consumer health.
Common questions
What to know about ONCE Ventures
Upseed classifies ONCE Ventures under the Corporate Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 3, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.